Balasa Dinverno & Foltz’s Concentrix CNXC Stock Holding History

Balasa Dinverno & Foltz’s Portfolio CNXC Stock Details CNXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$500K	Sell	4,478 -187	-4%	-$23.9K	0.03%	203
2022 Q2	$633K	Sell	4,665 -237	-5%	-$35.7K	0.04%	173
2022 Q1	$816K	Sell	4,902 -8	-0.2%	-$1.52K	0.06%	146
2021 Q4	$877K	Sell	4,910 -72	-1%	-$12.8K	0.06%	143
2021 Q3	$882K	Sell	4,982 -118	-2%	-$19.6K	0.06%	133
2021 Q2	$820K	Sell	5,100 -140	-3%	-$21.5K	0.06%	134
2021 Q1	$785K	Sell	5,240 -16	-0.3%	-$1.94K	0.06%	134
2020 Q4	$519K	Buy	+5,256	New	+$525K	0.04%	165

Other funds holding CNXC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Balasa Dinverno & Foltz's CNXC Position: Q3 2022 in Review

Balasa Dinverno & Foltz reduced its Concentrix (CNXC) stake by 4% in Q3 2022, selling an estimated $23.9K and leaving 4,478 shares worth $500K. The position accounts for 0.03% of the portfolio, ranked #203.

Balasa Dinverno & Foltz first reported a position in CNXC in Q4 2020 and has held it in 8 quarters since. The position peaked at $882K in Q3 2021. 313 funds tracked by Wall St. Rank hold CNXC as of Q3 2022.

Balasa Dinverno & Foltz held 4,478 shares of Concentrix worth $500K as of Q3 2022.
Balasa Dinverno & Foltz sold 187 Concentrix shares in Q3 2022, an estimated $23.9K.
Concentrix made up 0.03% of Balasa Dinverno & Foltz's portfolio in Q3 2022, its #203 holding.
Balasa Dinverno & Foltz first reported a position in Concentrix in Q4 2020 and has held it in 8 quarters since.
Balasa Dinverno & Foltz's Concentrix position peaked at $882K in Q3 2021.
313 funds tracked by Wall St. Rank held Concentrix as of Q3 2022.

Based on Balasa Dinverno & Foltz's 13F filing for Q3 2022, filed 25 Oct 2022.